Statins inhibit inflammatory reaction. CRP advances as a marker of coronary risk
MMW Fortschritte der Medizin 142(28-29): 54-55
2000
ISSN/ISBN: 1438-3276 PMID: 10959166 Document Number: 517255
Document emailed within 1 workday
Related Documents
Undas, A.; Brozek, J.; Musial, J. 2002: Anti-inflammatory and Antithrombotic Effects of Statins in the Management of Coronary Artery Disease Clinical Laboratory 48(5-6): 281-296Guţiu, I.A.; Galeţescu, E.; Guţiu, L.I.; Răducu, L. 1996: Diagonal earlobe crease: a coronary risk factor, a genetic marker of coronary heart disease, or a mere wrinkle. Ancient Greco-Roman evidence Romanian Journal of Internal Medicine 34(3-4): 271-278
Schäfer, H.; Ewig, S.; Hasper, E.; Koehler, U.; Oehm, S.; Pizzulli, L.; Lüderitz, B. 1996: Sleep apnea as a risk marker in coronary heart disease Zeitschrift für Kardiologie 85(10): 768-775
Cherkanova, M.S.; Korolenko, T.A.; Bravve, I.I.; Gerasimova, T.P. 2012: Effect of statins on activity of matrix metalloproteases and serum concentration of cystatin C in patients with various risk of development of ischemic heart disease and in patients after coronary artery bypass surgery Kardiologiia 52(2): 23-28
Fregnani, J.é H.T.G.; Soares, F.A.; Novik, P.R.; Lopes, A.; Latorre, M.d.R.ár.D.d.O. 2007: Intensity of cervical inflammatory reaction as a risk factor for recurrence of carcinoma of the uterine cervix in stages IB and IIA Sao Paulo Medical Journal 125(4): 231-236
Hansen, P.R.; Rasmussen, L.M.; Amtorp, O. 1999: Statins: a new group of anti-inflammatory agents? Ugeskrift for Laeger 161(31): 4421-4422
Krzesiek, E.; Iwańczak, B. 2010: Assessment of fecal calprotectin concentration as inflammatory marker in inflammatory bowel diseases in children--preliminary report Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego 29(172): 241-246
Jankowski, P.; Kawecka-Jaszcz, K. 2002: Statins in acute coronary syndromes Kardiologia Polska 57(11): 451-454
Linde, J.J.; Jensen, G.B. 2012: Early administrations of statins after acute coronary syndrome Ugeskrift for Laeger 174(26): 1801-1803
2003: Statins: new data in secondary prevention and diabetes. Pravastatin and simvastatin are the best-assessed statins Prescrire International 12(66): 143-148
Biasucci, L.M.; Stefanelli, A.; Biasillo, G. 2012: Statins and coronary artery disease: clinical evidence and future perspective Minerva Cardioangiologica 60(2): 147-156
Gaspardone, A.; Proietti, I.; Altamura, L.; Tomai, F.; Versaci, F.; Crea, F.; Chiariello, L.; Gioffrè, P.A. 2001: The use over time of statins in coronary patients in an Italian tertiary referral center Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 2(11): 848-853
Einecke, D. 2003: First comparison of 2 statins shows: only radical LDL lowering stops coronary atherosclerosis MMW Fortschritte der Medizin 145(51-52): 38
Carneiro, Aónio.Vaz.; Costa, Jão.; Borges, M. 2004: Statins for primary and secondary prevention of coronary heart disease. A scientific review Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 23(1): 95-122
Yonemitsu, Y.; Nakagawa, K.; Tanaka, S.; Mori, R.; Sugimachi, K.; Sueishi, K. 1996: In situ detection of frequent and active infection of human cytomegalovirus in inflammatory abdominal aortic aneurysms: possible pathogenic role in sustained chronic inflammatory reaction Laboratory Investigation; a Journal of Technical Methods and Pathology 74(4): 723-736
Yuan, Z.-y.; Liu, Y.; Liu, Y.; Zhang, J.-j.; Kishimoto, C.; Wang, Y.-n.; Ma, A.-q.; Liu, Z.-q. 2004: PPAR-gamma ligands inhibit the expression of inflammatory cytokines and attenuate autoimmune myocarditis Chinese Medical Journal 117(8): 1253-1255
Josefson 2000: Statins may reduce risk of Alzheimer's disease Bmj 321(7268): 1040
Toft-Petersen, A.Pernille.; Thomsen, R.Wernich.; Schmidt, E.Berg.; Larsen, T.Bjerregaard. 2011: Statins can maybe reduce the risk of venous thromboembolism Ugeskrift for Laeger 173(22): 1558-1563
Olsson, A.G. 2001: Emergency administration of statins in hospital. Measures concerning life style of coronary patients are still not to be forgotten Lakartidningen 98(22): 2704-2706
Sharma, R.; Mahajan, M.; Singh, B.; Bal, B.S.; Kant, R. 2006: Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients Journal of the Indian Medical Association 104(9): 492-498